https://www.thebodypro.com/category/hiv-treatment-strategies/tag/conference-coverage
HIV Treatment Strategies

Conference Coverage

The Latest

injection

Long-Acting Injectable HIV Treatment Still Appears Safe and Effective—and Largely Accessible Despite COVID-19 Disruptions

Research newly presented at the IDWeek 2020 conference yields further promising data on injectable cabotegravir/rilpivirine, as well as encouraging info regarding COVID-19 disruptions in treatment delivery.

By Larry Buhl
scale and tape measure

Flurry of New Research Explores Weight Gain on Integrase Inhibitors Among People Living With HIV

Taken together, these studies appear to confirm that weight gain is a class effect of INSTIs, albeit with potential differences between individual drugs—and much left to be learned about the health impact.

By Michael Broder
medical scale

More Research Points to Weight Increases on TAF-Containing HIV Treatment

Although the mechanism and long-term implications remain unclear, these studies affirm that the effect is occurring—and that a person’s prior HIV treatment regimen may play a role.

By Michael Broder
Black man talking with his doctor in office.

B/F/TAF Holds Up as Switch Regimen for Black People Living With HIV, Including Those With Resistance

While the most striking aspect of the study was its demographic focus, the baseline resistance profile of the participants was also key.

By Michael Broder
patient with COVID-19

HIV Status Does Not Affect COVID-19 Hospitalization, Short-Term Outcomes in Connecticut Hospital

The findings add to a growing body of research showing that it’s other co-morbidities, not HIV, that lead to worse health outcomes from COVID-19—at least among individuals who are on stable antiretroviral therapy.

By Larry Buhl
Ricardo Diaz

Researcher Behind "Brazil Patient," the Latest HIV Remission Case, Explains How It Happened

The international news story that broke at AIDS 2020, explained by the lead researcher.

By Terri Wilder, M.S.W.
Ricardo Diaz, M.D. (top left) shares findings regarding a potential new HIV remission case in a virtual press conference during the 23rd International AIDS Conference on July 7, 2020.

HIV Clinical Research Highlights From AIDS 2020, the 23rd International AIDS Conference

COVID-19 or no, there was still plenty to learn at this year's virtual conference, including for U.S. clinicians seeking to improve the care and treatment they provide to their patients living with HIV.

By Myles Helfand
hand showing 2

As Two-Drug HIV Treatment Rises, Long-Term Inflammation Becomes a Potential Concern

These studies presented at AIDS 2020 explore the benefits and challenges.

By Myles Helfand
pregnant check-up

Some Research on Pregnant and Postpartum Women with HIV Is Presented at CROI, But More Trials Are Needed

Pregnant people who are living with or vulnerable to HIV need to be included in clinical trials in order to close our knowledge gaps.

By Barbara Jungwirth
vaginal ring

Contraceptives Don’t Increase HIV Risk, but They Do Interact With Some Antiretrovirals

A CROI 2020 roundup of studies on birth control and women living with HIV.

By Barbara Jungwirth